Stein Schalkwijk, Angela Colbers and David Burger of the department of Pharmacy developed the Toolkit “Pregnant and breastfeeding women” in cooperation with Mark Mirochnick (Boston University, MA, USA) as a part of “Toolkit for research and development of paediatric antiretroviral drugs and formulations”.In 2016, an estimated 2.1 million children and 17.8 million women were living with HIV, and yet antiretroviral drug formulations for treating HIV among infants, children, adolescents and pregnant and breastfeeding women remain limited. Although well established legislative and regulatory frameworks support and stimulate the process of developing medicines for children, this process needs to be accelerated to ensure that much-needed antiretroviral formulations are available for children, especially those living in low- and middle-income countries.
This toolkit identifies the challenges and outlines possible solutions for promoting and accelerating timely and high-quality research and development of antiretroviral drug formulations suitable for infants, children, adolescents and pregnant and breastfeeding women. Although this toolkit focuses on HIV medicines, many of the principles outlined here can be applied to treatments for other diseases affecting pregnant women and children.
The toolkit can be found: https://globalhealthtrainingcentre.tghn.org/research-toolkit-paediatric-antiretroviral-drug-and-formulation-development/
Registration is free of charge.
This research is conducted within the theme Infectious diseases and global health.
Related news items
Research with twins sheds light on predisposition to overweight11 October 2018
The genetic predisposition to overweight has a greater effect in a living environment that promotes obesity. This was the conclusion of a study conducted at University College London (UCL). Ellen van Jaarsveld was one of the researchers.read more
Major grant for development of e-health program for cardiac rehabilitation11 October 2018
Maria Hopman is creating an e-health program for cardiac rehabilitation together with a consortium of Danish and Swiss companies. The consortium has been awarded a Eurostars grant of € 1.9 million.read more
Martine Hollander, Saskia de Wildt and Rianne van Boekel have been nominated for the VIVA400 Knappe Koppen11 October 2018
Martine Hollander, Saskia de Wildt and Rianne van Boekel have been nominated for the annual VIVA400 list. They have the chance to be awarded in the category Knappe Koppen. Please vote before 6 November.read more
The European Joint co-fund Programme for Rare Diseases (EJP-RD) approved9 October 2018
Radboudumc participates in the European Joint Programme on Rare Diseases (EJP-RD), which was recently approved by the European Commission.read more
Coach2Move highlighted by ZonMw Health care efficiency research program4 October 2018
On 26 September, ZonMw director Henk Smid handed over the evaluation of the Health care efficiency research program to Bas van den Dungen, Director-General of the Ministry of Health, Welfare and Sport.read more
Best clinical abstract award for Lando Janssen4 October 2018
During the annual John Goldman Conference on Chronic Myeloid Leukemia in Miami, Lando Janssen received the best clinical abstract award for his abstract entitled “Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia”.read more